Biomend OraGenix: Periodontal Screening Kit

Probing and radiographs show the damage. This shows the biology behind it.

Clinical exams and imaging measure damage that has already happened. Periodontal and peri-implant breakdown is driven by pathogen activity that can build for months before bone loss is visible. Biomend OraGenix moves that first signal earlier, to a stage where it can still be reversed. It supports your clinical judgement and does not replace it.

The 6 pathogens we profile

• Porphyromonas gingivalis – the keystone red-complex periodontal pathogen

• Tannerella forsythia – red complex, associated with deep-pocket tissue destruction

• Treponema denticola – red complex, associated with progressive periodontitis

• Fusobacterium nucleatum – the bridge organism linking early and late colonisers

• Prevotella intermedia – orange complex, linked to inflammation

• Aggregatibacter actinomycetemcomitans – tied to aggressive, early-onset disease and bone loss

What the report gives you

• Quantified pathogen levels from multiplex qPCR

• 3 AI risk scores: Overall Microbial Risk, Periodontal Inflammation Risk and Implant Failure Risk

• An overall score on a six-band scale from Very Low to Severe, weighing abundance, virulence and polymicrobial complexity

• A plain-language summary, with scores that stay comparable across re-tests

Best ordered for

Initial perio exams · Pre-implant workup · Non-responding or refractory cases · High-risk patients (smokers, diabetics) · Post-therapy re-tests

Swab to decision, under a week

1. Collect – a subgingival plaque or peri-implant sulcus fluid sample, in under 2 minutes chairside

2. Transport – room-temperature stable, no cold chain

3. Process – multiplex qPCR ( Result in 3 working days)

4. Report – pathogen levels, 3 AI risk scores and a plain-language summary

5. Act and monitor – re-test after therapy to confirm change

Built to fit chairside, not disrupt it.